News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Golembiewski Michael Joseph
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/31/2023 |
4
| Golembiewski Michael Joseph (CFO) has filed a Form 4 on SEELOS THERAPEUTICS, INC.|
Txns:
| Granted 677,701 options to buy
@ $0.69, valued at
$467.6k
Granted 88,030 options to buy
@ $0.69, valued at
$60.7k
|
|
| 03/02/2023 |
4
| Golembiewski Michael Joseph (CFO) has filed a Form 4 on SEELOS THERAPEUTICS, INC.|
Txns:
| Granted 12,500 shares
@ $0.672, valued at
$8.4k
|
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2022 |
4
| Golembiewski Michael Joseph (CFO) has filed a Form 4 on SEELOS THERAPEUTICS, INC.|
Txns:
| Granted 500,000 options to buy
@ $1.46, valued at
$730k
|
|
| 09/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/09/2017 |
4
| Golembiewski Michael Joseph (VP Finance, Controller, CAO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 3,300 shares
@ $0
Granted 10,000 options to buy
@ $2.92, valued at
$29.2k
|
|
|
|